Pharma trade targeted by Chinese regulators in antitrust push on scarce drugs, raw ingredients
China's National Development and Reform Commission and other Cinese regulators are drafting new guidelines to regulate the pricing of medicines that are in short supply and raw materials used to make...To view the full article, register now.
Already a subscriber? Click here to view full article